Eosinophil Lipid Bodies: Specific, Inducible Intracellular Sites for Enhanced Eicosanoid Formation

The specific intracellular sites at which enzymes act to generate arachidonate-derived eicosanoid mediators of inflammation are uncertain. We evaluated the formation and function of cytoplasmic lipid bodies. Lipid body formation in eosinophils was a rapidly (<1 h) inducible response which was platelet-activating factor (PAF) receptor–mediated, involved signaling through protein kinase C, and required new protein synthesis. In intact and enucleated eosinophils, the PAF-induced increases in lipid body numbers correlated with enhanced production of both lipoxygenase- and cyclooxygenase-derived eicosanoids. All principal eosinophil eicosanoid-forming enzymes, 5-lipoxygenase, leukotriene C4 synthase, and cyclooxygenase, were immunolocalized to native as well as newly induced lipid bodies in intact and enucleated eosinophils. Thus, lipid bodies are structurally distinct, inducible, nonnuclear sites for enhanced synthesis of paracrine eicosanoid mediators of inflammation.

[1]  H. Dvorak,et al.  Ultrastructural Immunogold Localization of Osteopontin in Human Gastric Mucosa , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[2]  William L. Smith,et al.  Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2* , 1996, The Journal of Biological Chemistry.

[3]  P. Bozza,et al.  Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Charles N. Serhan,et al.  Signalling the fat controller , 1996, Nature.

[5]  P. Bozza,et al.  Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids , 1996, The Journal of experimental medicine.

[6]  M. Triggiani,et al.  Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool , 1995, The Journal of experimental medicine.

[7]  S. Galli,et al.  Ultrastructural immunogold localization of subcellular sites of TNF‐α in colonic Crohn's disease , 1995, Journal of leukocyte biology.

[8]  D. Friend,et al.  Purification of human lung leukotriene C4 synthase and preparation of a polyclonal antibody. , 1995, American journal of respiratory and critical care medicine.

[9]  J. Otto,et al.  Different Intracellular Locations for Prostaglandin Endoperoxide H Synthase-1 and −2 (*) , 1995, The Journal of Biological Chemistry.

[10]  J. W. Woods,et al.  5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. , 1995, The Journal of clinical investigation.

[11]  A. Dvorak,et al.  Prostaglandin endoperoxide synthase (cyclooxygenase): ultrastructural localization to nonmembrane-bound cytoplasmic lipid bodies in human eosinophils and 3T3 fibroblasts. , 1994, International archives of allergy and immunology.

[12]  W. Henderson The Role of Leukotrienes in Inflammation , 1994, Annals of Internal Medicine.

[13]  J. Wu,et al.  Purification and Characterization of a High-Molecular-Weight Endogenous Glutamate-Binding Inhibitor in Porcine Brain. , 1994, Journal of biomedical science.

[14]  M. Peters-Golden,et al.  Localization of 5-lipoxygenase to the nucleus of unstimulated rat basophilic leukemia cells. , 1994, The Journal of biological chemistry.

[15]  J. Otto,et al.  The orientation of prostaglandin endoperoxide synthases-1 and -2 in the endoplasmic reticulum. , 1994, The Journal of biological chemistry.

[16]  G. Freeman,et al.  Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. W. Woods,et al.  5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes , 1993, The Journal of experimental medicine.

[18]  M. Peters-Golden,et al.  Redistribution of 5-lipoxygenase and cytosolic phospholipase A2 to the nuclear fraction upon macrophage activation. , 1993, Biochemical and biophysical research communications.

[19]  K. Austen,et al.  Purification of human leukotriene C4 synthase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  L. Lichtenstein,et al.  Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[21]  K. Blaser,et al.  An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. , 1991, Journal of immunological methods.

[22]  R. Wykle,et al.  Differential actions of diacyl- and alkylacylglycerols in priming phospholipase A2, 5-lipoxygenase and acetyltransferase activation in human neutrophils. , 1991, Biochimica et biophysica acta.

[23]  A. Dvorak,et al.  Cytoplasmic lipid bodies of neutrophils: formation induced by cis- unsaturated fatty acids and mediated by protein kinase C , 1991, The Journal of cell biology.

[24]  R. Dixon,et al.  Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis. , 1990, The Journal of biological chemistry.

[25]  G. Dusting,et al.  Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Dvorak,et al.  Cytoplasmic lipid bodies of human neutrophilic leukocytes. , 1989, The American journal of pathology.

[27]  R. Wykle,et al.  Phospholipase A2 activation in human neutrophils. Differential actions of diacylglycerols and alkylacylglycerols in priming cells for stimulation by N-formyl-Met-Leu-Phe. , 1988, The Journal of biological chemistry.

[28]  L. Roberts,et al.  Transformation of prostaglandin D2 to isomeric prostaglandin F2 compounds by human eosinophils. A potential mast cell-eosinophil interaction. , 1988, Journal of immunology.

[29]  C. Rouzer,et al.  Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. , 1988, The Journal of biological chemistry.

[30]  L. Touqui,et al.  Perspectives in platelet-activating factor research. , 1987, Pharmacological reviews.

[31]  S. Peters,et al.  Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links. , 1986, Journal of immunology.

[32]  R. Pagano,et al.  Defining lipid transport pathways in animal cells. , 1985, Science.

[33]  E. Corey,et al.  Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Roos,et al.  Functional activity of enucleated human polymorphonuclear leukocytes , 1983, The Journal of cell biology.

[35]  M. Karnovsky,et al.  Glycogen accumulation in polymorphonuclear leukocytes, and other intracellular alterations that occur during inflammation , 1982, The Journal of cell biology.

[36]  P. Schlesinger,et al.  Polyarthritis with birefringent lipid within synovial fluid macrophages: case report and ultrastructural study. , 1982, Arthritis and rheumatism.

[37]  S. Peters,et al.  Generation of leukotrienes by purified human lung mast cells. , 1982, The Journal of clinical investigation.

[38]  J. Weinstein Synovial fluid leukocytosis associated with intracellular lipid inclusions. , 1980, Archives of internal medicine.

[39]  H. Dvorak,et al.  Ultrastructural studies of macrophages: in vitro removal of cell coat with macrophage inhibition factor (MIF)-containing lymphocyte culture supernatants; chloroform extraction, phospholipase digestion, and autoradiographic studies. , 1980, Journal of the Reticuloendothelial Society.

[40]  G. Solley,et al.  Endomyocardiopathy with eosinophilia. , 1976, Mayo Clinic proceedings.

[41]  A. Lopes-Vaz,et al.  THE PRESENCE OF LIPID DROPLETS AND THE ABSENCE OF STABLE SUDANOPHILIA IN OSMIUM-FIXED HUMAN LEUKOCYTES , 1971, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[42]  C. Serhan,et al.  Eicosanoids in leukocyte function. , 1994, Current opinion in hematology.

[43]  P. Murphy The molecular biology of leukocyte chemoattractant receptors. , 1994, Annual review of immunology.

[44]  Harold E. Dvorak,et al.  Human Lung Mast Cell and Alveolar Macrophage Cytoplasmic Lipid Bodies Contain Arachidonic Acid and Prostaglandin Endoperoxide Synthase (Cyclooxygenase), the Substrate and Enzyme Necessary for Prostaglandin Production. , 1992, International archives of allergy and immunology.

[45]  H. Dvorak,et al.  Cytoplasmic lipid bodies of human eosinophils. Subcellular isolation and analysis of arachidonate incorporation. , 1991, The American journal of pathology.